Taken together, these findings imply that immunocompetence for IgM could be important in early pathological stages of Alzheimer’s disease [6], but that this effectiveness appears to wane as neurodegeneration advances or when dementia manifests. Here, CD40LG is linked to early-onset autosomal dominant Alzheimer disease.